Opioid crisis: no easy fix to its social and economic determinants N Dasgupta, L Beletsky, D Ciccarone American journal of public health 108 (2), 182-186, 2018 | 1081 | 2018 |
Cohort study of the impact of high-dose opioid analgesics on overdose mortality N Dasgupta, MJ Funk, S Proescholdbell, A Hirsch, KM Ribisl, S Marshall Pain medicine 17 (1), 85-98, 2016 | 396 | 2016 |
An analysis of the root causes for opioid-related overdose deaths in the United States LR Webster, S Cochella, N Dasgupta, KL Fakata, PG Fine, SM Fishman, ... Pain Medicine 12 (suppl_2), S26-S35, 2011 | 382 | 2011 |
Digital drug safety surveillance: monitoring pharmaceutical products in twitter CC Freifeld, JS Brownstein, CM Menone, W Bao, R Filice, T Kass-Hout, ... Drug safety 37, 343-350, 2014 | 342 | 2014 |
Project Lazarus: community-based overdose prevention in rural North Carolina S Albert, FW Brason, CK Sanford, N Dasgupta, J Graham, B Lovette Pain medicine 12 (suppl_2), S77-S85, 2011 | 280 | 2011 |
Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses C Ringwalt, H Gugelmann, M Garrettson, N Dasgupta, AE Chung, ... Pain Research and Management 19 (4), 179-185, 2014 | 186 | 2014 |
Association between non-medical and prescriptive usage of opioids N Dasgupta, ED Kramer, MA Zalman, S Carino Jr, MY Smith, JD Haddox, ... Drug and alcohol dependence 82 (2), 135-142, 2006 | 170 | 2006 |
Illicit use of opioids: Is OxyContin® a “gateway drug”? LE Grau, N Dasgupta, LE Grau, N Dasgupta, AP Harvey, LE Grau, ... American Journal on Addictions 16 (3), 166-173, 2007 | 150 | 2007 |
Evaluation of Facebook and Twitter monitoring to detect safety signals for medical products: an analysis of recent FDA safety alerts CE Pierce, K Bouri, C Pamer, S Proestel, HW Rodriguez, H Van Le, ... Drug safety 40, 317-331, 2017 | 136 | 2017 |
Public attitudes toward COVID-19 vaccination: The role of vaccine attributes, incentives, and misinformation S Kreps, N Dasgupta, JS Brownstein, Y Hswen, DL Kriner npj Vaccines 6 (1), 73, 2021 | 129 | 2021 |
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19 MC Figgatt, Z Salazar, E Day, L Vincent, N Dasgupta Journal of Substance Abuse Treatment 123, 108276, 2021 | 126 | 2021 |
Social media listening for routine post-marketing safety surveillance GE Powell, HA Seifert, T Reblin, PJ Burstein, J Blowers, JA Menius, ... Drug safety 39, 443-454, 2016 | 112 | 2016 |
Observed transition from opioid analgesic deaths toward heroin N Dasgupta, K Creppage, A Austin, C Ringwalt, C Sanford, ... Drug and alcohol dependence 145, 238-241, 2014 | 98 | 2014 |
Crowdsourcing black market prices for prescription opioids N Dasgupta, C Freifeld, JS Brownstein, CM Menone, HL Surratt, ... Journal of Medical Internet Research 15 (8), e2810, 2013 | 96 | 2013 |
Breaking the news or fueling the epidemic? Temporal association between news media report volume and opioid-related mortality N Dasgupta, KD Mandl, JS Brownstein PloS one 4 (11), e7758, 2009 | 95 | 2009 |
Recommendations for the use of social media in pharmacovigilance: lessons from IMI WEB-RADR J van Stekelenborg, J Ellenius, S Maskell, T Bergvall, O Caster, ... Drug Safety 42, 1393-1407, 2019 | 93 | 2019 |
Post-marketing surveillance of methadone and buprenorphine in the United States N Dasgupta, EJ Bailey, T Cicero, J Inciardi, M Parrino, A Rosenblum, ... Pain Medicine 11 (7), 1078-1091, 2010 | 83 | 2010 |
Ethics in a pandemic: a survey of the state pandemic influenza plans JC Thomas, N Dasgupta, A Martinot American Journal of Public Health 97 (Supplement_1), S26-S31, 2007 | 80 | 2007 |
Comparative rates of mortality and serious adverse effects among commonly prescribed opioid analgesics DL Murphy, JA Lebin, SG Severtson, HA Olsen, N Dasgupta, RC Dart Drug safety 41, 787-795, 2018 | 75 | 2018 |
Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone SG Severtson, MS Ellis, SP Kurtz, A Rosenblum, TJ Cicero, MW Parrino, ... Drug and alcohol dependence 168, 219-229, 2016 | 71 | 2016 |